TGA Provides Guidance on Handling Medicine and Medical Device Recalls in Australia
Stay informed about market actions and ensure compliance with TGA recall procedures
Effective from October 3, 2025
TGA | Pharmaceuticals | Country Regulatory AffairsPMDA Issues Year-End Guidance for Clinical Trial Plan Submissions
Timely submissions and compliance with Japan’s
clinical trial notification procedures during the holiday season.Effective from October 6, 2025
PMDA | Pharmaceuticals | Country Regulatory AffairsPMDA Issues Guidance on Handling Prescription Drugs with Different Crystalline Forms
Japan’s latest regulatory update ensuring quality
equivalence and clarity in drug approvals.Effective from October 10, 2025
NMPA | Pharmaceuticals | Country Regulatory AffairsState Medical Products Administration Announces Protected Variety of Traditional Chinese Medicine (China)
Explore China’s First Second-Level Protected Traditional Chinese Medicine, today!
The initiative came into effect on 09-Oct-2025
NMPA | Pharmaceuticals | Country Regulatory AffairsNingxia region (China) Introduces Measures to Reform Drug and Device Supervision
Explore New Initiatives for High-Quality Pharmaceutical Development in China, today!
The initiative came into effect on 11-Oct-2025
NMPA | Pharmaceuticals | Country Regulatory Affairs
Consult
